HERO (Haemophilia Experiences, Results and Opportunities) is an international initiative guided by the HERO International Advisory Board and supported by Novo Nordisk. HERO aims to build a comprehensive understanding of life with haemophilia as seen from the perspective of people with haemophilia, their families and their healthcare providers.
Giving haemophilia a voice.
The goal of HERO is to:
Visit www.herostudy.org to learn more.
Completed in 2012, the HERO study surveyed 1,386 people in 11 countries, making it the largest ever multi-national, multi-method study of life with haemophilia. The HERO study has given us some key insights into the challenges facing people living with haemophilia.